These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3914589)

  • 1. [Cellulitis. Study of microangiopathy in 254 cases].
    Segers AM; de Forteza IE; Abulafia J
    Med Cutan Ibero Lat Am; 1985; 13(5):385-90. PubMed ID: 3914589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cellulitis. Histopathologic and histochemical study of 100 cases].
    Segers AM; Abulafia J; Kriner J; Cortondo O
    Med Cutan Ibero Lat Am; 1984; 12(2):167-72. PubMed ID: 6233464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Skin manifestations in diabetes mellitus].
    Herzberg JJ
    Hautarzt; 1974 Dec; 25(12):579-84. PubMed ID: 4280990
    [No Abstract]   [Full Text] [Related]  

  • 4. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy].
    Peczyńska J; Urban M; Głowińska B; Urban B
    Pol Merkur Lekarski; 2003 Apr; 14(82):336-9. PubMed ID: 12868196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in microcirculation and selected laboratory parameters in the early stages of diabetic microangiopathy].
    Skrha J; Prázný M; Kvasnicka J; Kalvodová B
    Cas Lek Cesk; 2001 Jun; 140(12):370-4. PubMed ID: 11503186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alpha2-macroglobulin in diabetic disease and in its microangiopathic complications].
    Volpi A; Piaserico PL
    Minerva Med; 1983 Oct; 74(39):2287-9. PubMed ID: 6197682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil surface expression of CD11b and CD62L in diabetic microangiopathy.
    Mastej K; Adamiec R
    Acta Diabetol; 2008 Sep; 45(3):183-90. PubMed ID: 18496641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between the level of plasma D-dimer and diabetic microangiopathy].
    Long ZF; Qu GY; Xu M
    Hunan Yi Ke Da Xue Xue Bao; 2001 Oct; 26(5):434-6. PubMed ID: 12536492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with diabetes-induced microangiopathy show a reduced frequency of carcinomas.
    Nerlich AG; Hagedorn HG; Böheim M; Schleicher ED
    In Vivo; 1998; 12(6):667-70. PubMed ID: 9891230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative DNA damage and augmentation of poly(ADP-ribose) polymerase/nuclear factor-kappa B signaling in patients with type 2 diabetes and microangiopathy.
    Adaikalakoteswari A; Rema M; Mohan V; Balasubramanyam M
    Int J Biochem Cell Biol; 2007; 39(9):1673-84. PubMed ID: 17540609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-prandial hyperglycemia is an important predictor of the incidence of diabetic microangiopathy in Japanese type 2 diabetic patients.
    Shiraiwa T; Kaneto H; Miyatsuka T; Kato K; Yamamoto K; Kawashima A; Kanda T; Suzuki M; Imano E; Matsuhisa M; Hori M; Yamasaki Y
    Biochem Biophys Res Commun; 2005 Oct; 336(1):339-45. PubMed ID: 16140262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetic microangiopathy (based on the morphological study data from skin biopsies)].
    Saltykov BB
    Arkh Patol; 1981; 43(3):42-7. PubMed ID: 7236031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of diabetic microangiopathy and diabetic control. A study in non-insulin-dependent diabetics.
    Maneschi F; Cassar J; Lowy C; Kohner EM
    Diabete Metab; 1981 Sep; 7(3):181-7. PubMed ID: 7033009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetes mellitus. 8. Kidney complications in diabetes mellitus. The problem of microangiopathy].
    Bruns W; Langsch HG
    Z Arztl Fortbild (Jena); 1970 Jun; 64(12):587-92. PubMed ID: 5519342
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic heterogeneity in diabetes mellitus and diabetic microangiopathy.
    Rimoin DL; Rotter JI
    Horm Metab Res Suppl; 1981; 11():63-72. PubMed ID: 6947951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Could lymph node microangiopathy play a part in the immunodeficiency of diabetes? Histological and immunohistochemical study of lymph nodes from 4 patients with long-term insulin-dependent diabetes mellitus subjected to autopsy examination].
    Muretto P
    Pathologica; 1997 Jun; 89(3):274-81. PubMed ID: 9380421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cellulite].
    Segers AM; de Forteza IE; Conforti FY; Abulafia J
    Med Cutan Ibero Lat Am; 1985; 13(6):539-44. PubMed ID: 3914608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular basis of diabetic microangiopathy.
    Mokini Z; Chiarelli F
    Pediatr Endocrinol Rev; 2006 Dec-2007 Jan; 4(2):138-52. PubMed ID: 17342030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of growth factor levels in adolescents with type 1 diabetes mellitus and the beginning of diabetic microangiopathy].
    Peczyńska J; Urban M; Urban B; Głowińska B; Florys B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(1):41-8. PubMed ID: 15355738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.